Evidence map›Paper›PMID 41206768›Full record

ArticleNucleic acids research2026

RM2Target v2.0: an updated database for the target genes of writers, erasers, and readers of RNA modifications.

Xiaoqiong Bao, Qi Jiang, Weixuan Chen, Huiqin Li, Xuanye Li, Xiangyu Zuo, Zhuobin Lin, Yuantai Huang, Lingxiao Li, Anli Yang and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. A functional map of mNature cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaoqiong BaoSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Qi JiangSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Weixuan ChenSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Huiqin LiSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Xuanye LiSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Xiangyu ZuoCollege of life and environmental sciences, Hunan University of Arts and Science, Changde, Hunan 415000, China.
Zhuobin LinGuangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou 510060, China.
Yuantai HuangSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Lingxiao LiSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Anli YangSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.
Jian RenSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-4161-1292
Zhixiang ZuoSchool of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-2492-2689

Funding

Guangdong Esophageal Cancer Institute Science and Technology Program M202206National Key Research and Development Program of China 2023YFF1204600National Natural Science Foundation of China 32470709National Natural Science Foundation of China 82573769Research and Development Program of China 2023YFF1204600Shenzhen Medical Research Fund B2402019Young Talents Program of Sun Yat-sen University Cancer Center YTP-SYSUCC-0013
6 · The paper itself

Abstract

Defining regulatory associations between RNA modification proteins [writers, erasers, and readers (WERs)] and their target genes is crucial for elucidating the molecular mechanisms underlying RNA modifications. We previously developed RM2Target, a comprehensive database of WER-target associations across nine RNA modification types in humans and mice, which has become a widely utilized resource in the field. However, the growing body of research on novel RNA modifications and non-model species has created an urgent need for a significant expansion of the database. Here, we introduce RM2Target v2.0 (http://rm2target.canceromics.org/), an updated version featuring substantially expanded data coverage and enhanced curation. The new release includes 4 400 616 WER-target associations, encompassing 273 WER proteins from 18 RNA modification types and spanning 973 cell lines or tissues across 20 species. Additionally, RM2Target v2.0 provides extensive annotations for target genes, including basic gene information, associated RNA modifications, RNA-RNA and RNA-protein interactions, and disease linkages. We expect that RM2Target v2.0 will serve as a foundational resource for exploring RNA epitranscriptomic regulation, enabling investigations into cross-talk among modifications, underlying molecular mechanisms, and disease connections, thereby facilitating both basic research and translational applications in RNA epigenetics.

Indexed as

Databases, GeneticRNARNA-Binding ProteinsRNA Processing, Post-TranscriptionalAnimalsHumansMiceMolecular Sequence AnnotationRNARNA-Binding Proteins

Identifiers

PMID41206768
PMCPMC12807602

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.